Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD)

NCT01089127 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

552

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Indacaterol
DRUG: Salmeterol 50 μg
DRUG: Placebo to indacaterol
DRUG: Placebo to salmeterol

Sponsor

Novartis Pharmaceuticals